Summary
All male inhabitants of the city of Göteborg, who were born between 1915–1922 and 1924–1925 were included in the trial, and were 47 to 55 years of age on entry to the study in 1970 to 1973. One-third of these men were randomly allocated to an intervention group, whilst the other two-thirds acted as controls. Men of all social classes, employed as wellas unemployed, health conscious as well as careless, were invited, with 75% of these responding to the invitation. The intervention group contained 10,000 men and the control group 20,000 men.
The intervention group were given advice on diet, both individually and in groups, the type of advice depending upon serum cholesterol level. Smokers were advised to stop smoking, and men with elevated blood pressure were treated with antihypertensive drugs.
Due to the large size of the groups and because they formed a random population sample, it was assumed that they had similar characteristics at the start of the trial. Risk factors were only measured in the intervention group at this time, followed by intervention. This design feature solved several ethical problems with regard to no treatment in the control group. These men were, however, subjected to health examinations and treatment as well as general health advice.
Risk factor levels were measured in the intervention group, and also in random subsamples (11%) of the control group after 4 and 10 years. Serum cholesterol, blood pressure and smoking decreased among men in both groups, and only slightly more in the intervention group. Antihypertensive drug treatment was given to 26% of the intervention group and 20% of the control group participants after 10 years.
No significant effect on total or cardiovascular mortality, or on the incidence of myocardial infarction or stroke was found. However, the effect of this intensive antihypertensive treatment on mortality and morbidity is indicated when the present results are compared to those of a previous population study in the same city.
A markedly higher mortality in the group of non-participants diluted the results considerably, and some characteristics of this group will be discussed in view of future possibilities of prevention efforts in the whole community.
Similar content being viewed by others
References
Elmfeldt D, Wilhelmsen L, Tibblin G, et al. Registration of myocardial infarction in the city of Göteborg, Sweden. A community study. Journal of Chronic Diseases 28: 173–186, 1975
Harmsen P, Tibblin G. A stroke register in Göteborg, Sweden. Acta Medica Scandinavica 191: 463–470, 1972
Hjermann I, Holme I, Byre KV, et al. Effect of diet and smokingintervention on the incidence of coronary heart disease. Lancet 2: 1303–1310, 1981
LRCP (Lipid Research Clinics Program). The Lipid Research Clinics Primary Prevention Trial results. 1. Reduction in incidence of coronary heart disease. Journal of the American Medical Association 251: 351–364, 1984
MRFIT (Multiple Risk Factor Intervention Trial Research Group). Multiple Risk Factor Intervention Trial. Risk factor changes and mortality results. Journal of the American Medical Association 248: 1465–1477, 1982
Oden A, Wedel H. Arguments for Fisher’s permutation test. Annals of Statistics 3: 518–528, 1975
Pyorala K, Salonen JT, Valkonen T. Trends in coronary heart disease mortality and morbidity and related factors in Finland. Cardiology 72: 35–51, 1985
Stamler J. The marked decline in coronary heart disease mortality rates in the United States, 1968–1981; summary of findings and possible explanations. Cardiology 72: 11–22, 1985
Tibblin G. High blood pressure in men aged 50. A population study of men born in 1913. Acta Medica Scandinavica (Suppl. 470): 1967
Welin L, Svardsudd K, Larsson B, et al. Why is the incidence of ischemic heart disease in Sweden increasing? Study of men born in 1913 and 1923. Lancet 1: 1087–1090, 1983
WHO (World Health Organization Report of an Expert Committee). The prevention of coronary heart disease. WHO Technical Report Series No. 678, 1982
WHO (World Health Organization European Collaborative Group). Multifactorial trial in the prevention of coronary heart disease. 3. Incidence and mortality results. European Heart Journal 4: 141–147, 1983
Wilhelmsen L, Tibblin G, Werko L. A primary preventive study in Gothenburg, Sweden. Preventive Medicine 1: 153–160, 1972
Wihelmsen L. What should the public be told about primary prevention of CHD? European Heart Journal 5: 434–439, 1984
Wilhelmsen L, Elmfeldt D, Berglund G, et al. The Multifactor Primary Prevention Trial in Gothenburg, Sweden. European Heart Journal, in press.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Wilhelmsen, L., Berglund, G., Elmfeldt, D. et al. The Multifactor Primary Prevention Trial in Göteborg, Sweden. Drugs 31 (Suppl 1), 47–51 (1986). https://doi.org/10.2165/00003495-198600311-00009
Published:
Issue Date:
DOI: https://doi.org/10.2165/00003495-198600311-00009